Inflammatory Pseudotumor Presenting as a Cystic Tumor of the Pancreas

Liu, Terrence H.; Consorti, Eileen T.
November 2000
American Surgeon;Nov2000, Vol. 66 Issue 11, p993
Academic Journal
Inflammatory pseudotumor (IPT) of the pancreas occurs rarely. Eighteen cases have been described in the English literature. In all previous patients IPT of the pancreas presented as solid pancreatic mass. We are reporting a case of IPT presenting as a cystic mass of the pancreas, which has not been described previously. A review of IPT of the pancreas and a discussion regarding the management of pancreatic cystic neoplasm is provided.


Related Articles

  • A case of vague abdominal pain. Surawicz, Christina M. // Cortlandt Forum;10/25/96, Vol. 9 Issue 10, p182 

    Details a case where a 58-year-old man was diagnosed with cystic neoplasms of the pancreas. Presenting symptoms; Differential diagnosis for the condition; Incidence of the disease; Differentiation from pseudocysts.

  • Early Detection of Pancreatic Cancer following the Diagnosis of Chronic Pancreatitis. Talamini, Giorgio; Bassi, C.; Falconi, M.; Sartori, N.; Pasetto, M.; Salvia, R.; Di Francesco, V.; Frulloni, L.; Vaona, B.; Bovo, P.; Pederzoli, P.; Cavallini, G. // Digestion;1999, Vol. 60 Issue 6, p554 

    Aim: To assess whether patients with misdiagnoses of chronic pancreatitis (CP), followed at an early stage by a diagnosis of pancreatic cancer (PCr), present different epidemiological characteristics from patients suffering either from CP alone or from CP with late degeneration to PCr. Methods:...

  • Advances in Pancreatic Cancer Detection and Prevention. Gonzales, Joseph; Levin, Susan // Good Medicine;Winter2011, Vol. 20 Issue 1, p17 

    The article reports that it takes about 6.8 years for a pancreatic cancer cell to spread to other human body organs and around 2.7 years from then before the death of a patient, which is based on a study published in the 2010 issue of "Nature."

  • Outcomes of Peptide Receptor Radionuclide Therapy (PRRT) in North American Cohort of Patients with Metastatic Well-Differentiated Neuroendocrine Tumors (mNETs). Naraev, B.; Sharma, N.; Engelman, E.; Bushnell, D.; O'Dorisio, T.; Halfdanarson, T. // Neuroendocrinology;Jul2012 Supplement, Vol. 96, p50 

    Introduction: PRRT is an accepted treatment in Europe for patients (pts) with mNETs, but considered investigational in the USA. Aim(s): To describe the University of Iowa (UI) experience with PRRT. Materials and methods: One-hundred and thirty-five cases from the UI NET database were analyzed...

  • Endoscopic Ultrasound-Guided Fine Needle Tissue Acquisition (EUS-FNTA) Using a 19-G Needle for Histological Grading of Pancreatic Endocrine Tumors (PETs): A Prospective Study. Larghi, A.; Fusco, A.; Bianchi, A.; Lugli, F.; Iacovazzo, D.; Celico, M.; Costamagna, G.; Pontecorvi, A.; Rindi, G.; De Marinis, L. // Neuroendocrinology;Jul2012 Supplement, Vol. 96, p44 

    Introduction: EUS-FNTA is increasingly used in the diagnosis of pancreatic endocrine tumors (PETs). Ki-67 expression, an important prognostic factor according to the WHO classification, is difficult to be determined on cytological specimens. Aim(s): We prospectively evaluated the feasibility and...

  • The Role of Combined Ga-DOTANOC and 18FDG PET/CT in the Management of Patients with Pancreatic Neuroendocrine Tumors. Partelli, Stefano; Rinzivillo, Maria; Maurizi, angela; Panzuto, Francesco; Salgarello, Matteo; Polenta, Vanessa; Delle Fave, Gianfranco; Falconi, Massimo // Neuroendocrinology;Feb2015, Vol. 100 Issue 4, p293 

    Purpose: The aim of this study was to evaluate the effect of combined 68Ga and 18F-FDG PET/CT on treatment management for patients with pancreatic neuroendocrine tumor (PNET). Methods: Between January 2012 and April 2014, 49 consecutive patients with a cytologically and/or histologically proven...

  • Endoscopic Ultrasound Features of Multiple Endocrine Neoplasia Type 1-Related versus Sporadic Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Study. Tamagno, Gianluca; Scherer, Vanessa; Caimo, Alberto; Bergmann, Simona R.; Kann, Peter H. // Digestion;Aug2018, Vol. 98 Issue 2, p112 

    Aim: Pancreatic neuroendocrine tumors (pNETs) can occur in patients with a familial syndrome either as multiple endocrine neoplasia type 1 (MEN-1) or as sporadic tumors. Endoscopic ultrasound (EUS) has become one of the first-line investigations for pNET characterization. The...

  • Whole Blood DNA Aberrant Methylation in Pancreatic Adenocarcinoma Shows Association with the Course of the Disease: A Pilot Study. Dauksa, Albertas; Gulbinas, Antanas; Barauskas, Giedrius; Pundzius, Juozas; Oldenburg, Johannes; El-Maarri, Osman // PLoS ONE;May2012, Vol. 7 Issue 5, p1 

    Pancreatic tumors are usually diagnosed at an advanced stage in the progression of the disease, thus reducing the survival chances of the patients. Non-invasive early detection would greatly enhance therapy and survival rates. Toward this aim, we investigated in a pilot study the power of...

  • Diarrhea Associated with Retroperitoneal Tumor. Gupta, Nikhil; Ranjan, Gyan; Chaudhary, Poras; Arora, MP // Oman Medical Journal;May2014, Vol. 29 Issue 3, p242 

    The article offers a test about the diagnosis of a patient who is presented to the surgical outpatient department for watery diarrhea associated with weight loss, abdominal pain and anorexia.

  • Analysis of β-Catenin Gene Mutations in Pancreatic Tumors. Gerdes, Berthold; Ramaswamy, Annette; Simon, Babette; Pietsch, Torsten; Bastian, Daniel; Kersting, Michael; Moll, Roland; Bartsch, Detlef // Digestion;1999, Vol. 60 Issue 6, p544 

    Background/Aim: Mutations of the adenomatous polyposis coli (APC) tumor suppressor gene have been described in a subset of pancreatic carcinomas. The APC gene modulates the β-catenin-Tcf pathway. The major player in this pathway is the β-catenin protein encoded by the β-catenin gene. A...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics